Canaccord Genuity analyst Richard Close maintained a Buy rating on Option Care Health (NASDAQ:OPCH) on Friday, setting a price target of $22, which is approximately 25.14% above the present share price of $17.58.
Close expects Option Care Health to post earnings per share (EPS) of $0.10 for the second quarter of 2021.
The current consensus among 3 TipRanks analysts is for a Strong Buy rating of shares in Option Care Health, with an average price target of $23.17.
The analysts price targets range from a high of $24 to a low of $22.
In its latest earnings report, released on 12/31/2020, the company reported a quarterly revenue of $804.71 million and a net profit of $44.34 million. The company's market cap is $3.16 billion.
According to TipRanks.com, Canaccord Genuity analyst Richard Close is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 26.5% and a 61.42% success rate.
Option Care Health, Inc. provides home and alternate site infusion services. The company was founded in 1996 and is headquartered in Bannockburn, IL.